Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1993-09-15
1995-02-28
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514 21, C07G 700, A61K 3702, A61K 3532, A61K 3712
Patent
active
053937392
ABSTRACT:
Bone morphogenetic proteins -2 and -3 (BMPs -2 and -3) work in synergistic combination with TGF-.beta.z to provide compositions with increased osteogenic activity. Methods of treating bone defects, inducing bone growth and increasing bone marrow cell production using these compositions are also disclosed.
REFERENCES:
patent: 4294753 (1981-10-01), Urist
patent: 4434094 (1984-02-01), Seyedin et al.
patent: 4455256 (1984-06-01), Urist
patent: 4563489 (1986-01-01), Urist
patent: 4608199 (1986-08-01), Caplan et al.
patent: 4774322 (1988-09-01), Seyedin et al.
patent: 4789732 (1988-12-01), Urist
patent: 4795804 (1989-01-01), Urist
patent: 4806523 (1989-02-01), Bentz et al.
patent: 4877864 (1989-10-01), Ways et al.
patent: 4886747 (1989-12-01), Derynk et al.
Bentz et al., "Cartilage Induction and Differentiation: The Role of Bone-Derived Cartilage Inducing Factor (CIF-A)", in Development and Diseases of Cartilage and Bone Matrix, pp. 137-147, 1987, Alan R. Liss, Inc.
Urist et al., "Surface-decalcified allogeneic bone (SDAB) implants", Clin. Orthop. & Rel. Res., (1968), 56:37-50.
Urist et al., "Bone: Formation by autoinduction", Science, (1965), 150:893-899.
Reddi et al., "Biochemical sequences in the transformation of normal fibroblasts in adolescent rats", Proc. Natl. Acad. Sci., (1972), 69:1601-1605.
Urist et al., "A bovine low molecular weight bone morphogenetic protein (BMP) fraction", Clin. Orthop. Rel. Res., (1982), 162:219-232.
Urist et al., "Bone cell differentiation and growth factors", Science, (1965), 150:893-899.
Urist et al., "Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography", Proc. Natl. Acad. Sci., (1984), 81:371-375.
Wozney, J. M., "Bone morphogenetic proteins", Growth Factor Research, (1989), 1:267-280.
Ozkaynak et al., "OP-1 cDNA encodes an osteogenic proteins in the TGF-.beta. family", EMBO J., (1990), 9:2085-2093.
Sampath et al., "Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-.beta. superfamily", J. Biol. Chem., (1990), 265:13198-13205.
Jakowlew et al., "Complementary deoxyribonucleic acid cloning of a messenger ribonucleic acid encoding transforming growth factor .beta.4 from chicken embryo chondrocytes", Molec. Endocrinol., (1982), 2:1186-1195.
Roberts et al., "Isolation and characterization of TGF-.beta.2 and TGF-.beta.5 from medium conditioned by Xenopus XTC cells", Growth Factors, (1990), 2:135-147.
Bentz et al., "Purification and characterization of a unique osteroinductive factor from bovine bone", J. Biol. Chem., (1989), 264(32):20805-20810.
Sen, A., et al., (eds.), Development and Diseases of Cartilage and Bone Matrix, Alan R. Liss, Inc., New York, (1987), pp. 137-147.
Kawamura et al., "Growth factors, mitogens, cytokines, and bone morphogenic protein in induced chondrogenesis in tissue culture", Developmental Biology, (1988), 130:435-442.
Reddi et al., "Bone induction by osteogenin and bone morphogenetic proteins", Biomaterials, (1990), 11:33-34.
Reddi et al., "Initiation of bone development by osteogenin and promotion by growth factors", Connective Tissue Research, (1989), 20:303-311.
Bentz et al., "Transforming growth factor-.beta.2 enhances the osteoinductive activity of a bovine bone-derived fraction containing bone morphogenic protein-2 and 3", Matrix, (1991), 11:269-275.
Kukita et al., "Osteoinductive factor inhibits formation of human osteoclast-like cells", Proc. Natl. Acad. Sci., (1990), 87:3023-3026.
Bonewald et al., "Role of transforming growth factor-beta in bone remodeling", Clinical Orthopaedics and Related Research, (1990), 250:261-276.
Centrella et al., "Transforming growth factor .beta. is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone", J. Biol. Chem., (1987), 262(6):2869-2874.
Robey et al., "Osteoblasts synthesize and responsed to transforming growth factor-type .beta. (TGF-.beta.) in vitro", J. Cell. Biol., (1987), 105:457-463.
Rosen et al., "Transforming growth factor-beta modulates the expression of osteoblast and chondroblast phenotypes in vitro", J. Cell. Physiol., (1988), 134:337-346.
Armstrong Rosa
Bentz Hanne
Rosen David M.
Thompson Andrea Y.
Celtrix Pharmaceuticals Inc.
Schain Howard E.
Touzeau P. Lynn
LandOfFree
Use of bone morphogenetic protein in synergistic combination wit does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of bone morphogenetic protein in synergistic combination wit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of bone morphogenetic protein in synergistic combination wit will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-848570